Liisa Volin

14.5k total citations
210 papers, 7.0k citations indexed

About

Liisa Volin is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Liisa Volin has authored 210 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Hematology, 50 papers in Public Health, Environmental and Occupational Health and 41 papers in Oncology. Recurrent topics in Liisa Volin's work include Hematopoietic Stem Cell Transplantation (122 papers), Acute Myeloid Leukemia Research (72 papers) and Acute Lymphoblastic Leukemia research (48 papers). Liisa Volin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (122 papers), Acute Myeloid Leukemia Research (72 papers) and Acute Lymphoblastic Leukemia research (48 papers). Liisa Volin collaborates with scholars based in Finland, France and Germany. Liisa Volin's co-authors include Tapani Ruutu, T Parkkali, Myriam Labopin, Mohamad Mohty, Per Ljungman, Petri Ruutu, Arnon Nagler, Eeva Juvonen, Vanderson Rocha and Olle Ringdén and has published in prestigious journals such as New England Journal of Medicine, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Liisa Volin

205 papers receiving 6.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liisa Volin Finland 45 4.6k 1.8k 1.4k 1.3k 1.2k 210 7.0k
Hisashi Sakamaki Japan 41 4.1k 0.9× 1.4k 0.8× 1.3k 0.9× 1.0k 0.8× 1.1k 0.9× 304 6.4k
Rainer Schwerdtfeger Germany 43 4.3k 0.9× 1.4k 0.7× 1.2k 0.8× 860 0.7× 1.3k 1.1× 126 6.0k
Rafael F. Duarte Spain 39 3.3k 0.7× 1.8k 1.0× 1000 0.7× 1.3k 1.0× 1.0k 0.9× 163 6.1k
Hildegard Greinix Austria 47 5.6k 1.2× 1.9k 1.0× 1.2k 0.9× 1.4k 1.1× 2.6k 2.1× 244 8.9k
Maria Teresa Van Lint Italy 47 4.7k 1.0× 1.7k 0.9× 1.2k 0.8× 1.0k 0.8× 1.5k 1.2× 133 6.4k
Agnès Buzyn France 44 3.0k 0.7× 1.5k 0.8× 1.9k 1.3× 715 0.6× 1.0k 0.9× 137 5.7k
Salut Brunet Spain 45 4.2k 0.9× 1.6k 0.9× 1.4k 1.0× 867 0.7× 1.1k 0.9× 201 6.7k
Dietrich W. Beelen Germany 45 5.2k 1.1× 1.5k 0.8× 1.4k 1.0× 991 0.8× 2.0k 1.6× 322 7.4k
George E. Sale United States 37 4.5k 1.0× 1.7k 0.9× 935 0.7× 1.0k 0.8× 2.1k 1.7× 97 7.4k
Tapani Ruutu Finland 51 6.8k 1.5× 2.1k 1.2× 1.8k 1.2× 1.3k 1.0× 1.5k 1.2× 221 10.2k

Countries citing papers authored by Liisa Volin

Since Specialization
Citations

This map shows the geographic impact of Liisa Volin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liisa Volin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liisa Volin more than expected).

Fields of papers citing papers by Liisa Volin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liisa Volin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liisa Volin. The network helps show where Liisa Volin may publish in the future.

Co-authorship network of co-authors of Liisa Volin

This figure shows the co-authorship network connecting the top 25 collaborators of Liisa Volin. A scholar is included among the top collaborators of Liisa Volin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liisa Volin. Liisa Volin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Díaz‐Beyá, Marina, Myriam Labopin, Johan Maertens, et al.. (2020). Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK‐NUP214 shows a favourable outcome when performed in first complete remission. British Journal of Haematology. 189(5). 920–925. 14 indexed citations
3.
Poiré, Xavier, Myriam Labopin, Emmanuelle Polge, et al.. (2018). Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission. American Journal of Hematology. 94(2). 231–239. 13 indexed citations
4.
Przybyla, Beata, Jari Petäjä, Lotta Joutsi‐Korhonen, et al.. (2017). Coordinated responses of natural anticoagulants to allogeneic stem cell transplantation and acute GVHD – A longitudinal study. PLoS ONE. 12(12). e0190007–e0190007. 4 indexed citations
7.
Björkstrand, Bo, Simona Iacobelli, Ute Hegenbart, et al.. (2011). Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up. Journal of Clinical Oncology. 29(22). 3016–3022. 118 indexed citations
8.
Schetelig, Johannes, Don Milligan, D Niederwieser, et al.. (2009). In vivo T-cell depletion in allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: a retrospective EBMT analysis. Bone Marrow Transplantation. 43. 2 indexed citations
9.
Iacobelli, Stefano, Ute Hegenbart, Astrid Gruber, et al.. (2008). Autologous stem cell transplantation (ASCT) vs ASCT followed by reduced-intensity conditioning allogeneic SCT with identical sibling donor in previously untreated multiple myeloma: preliminary analysis of a prospective controlled trial by the EBMT. Bone Marrow Transplantation. 41. 1 indexed citations
11.
Jantunen, Esa, et al.. (2004). Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis. Bone Marrow Transplantation. 34(10). 891–895. 19 indexed citations
12.
Jantunen, Esa, Liisa Volin, Oili Salonen, et al.. (2003). Central nervous system aspergillosis in allogeneic stem cell transplant recipients. Bone Marrow Transplantation. 31(3). 191–196. 39 indexed citations
13.
Juvonen, Eeva, Jussi Tarkkanen, Liisa Volin, et al.. (2003). High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment. Bone Marrow Transplantation. 32(1). 97–102. 54 indexed citations
14.
Juvonen, Eeva, et al.. (2002). Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome. Bone Marrow Transplantation. 29(5). 457–458. 30 indexed citations
15.
Jantunen, Esa, Anneli Piilonen, Liisa Volin, et al.. (2002). Radiologically guided fine needle lung biopsies in the evaluation of focal pulmonary lesions in allogeneic stem cell transplant recipients. Bone Marrow Transplantation. 29(4). 353–356. 10 indexed citations
16.
Jantunen, Esa, Anneli Piilonen, Liisa Volin, et al.. (2000). Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplantation. 25(8). 867–871. 48 indexed citations
17.
Kinnunen, Kati, Liisa Volin, Riitta Tähtelä, et al.. (1999). A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplantation. 23(4). 355–361. 86 indexed citations
18.
Jantunen, Esa, Elina Kolho, Petri Ruutu, et al.. (1996). Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation.. PubMed. 18(1). 229–30. 17 indexed citations
19.
Wessman, Maija, Susanne Popp, Tapani Ruutu, et al.. (1993). Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization and karyotype analysis.. PubMed. 11(4). 279–84. 42 indexed citations
20.
Volin, Liisa, et al.. (1989). MONITORING OF BONE MARROW TRANSPLANT RECIPIENT LIVER BY FINE-NEEDLE ASPIRATION BIOPSY. Transplantation. 48(6). 969–973. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026